Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression [Yahoo! Finance]
Neuronetics, Inc. (STIM)
Last neuronetics, inc. earnings: 3/3 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
NeuroStar is the first and only FDA-approved transcranial magnetic stimulation (TMS) treatment available for this age group. TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of major depression. Price Performance In the past six months, STIM's shares have rallied 263.4% compared with the industry's rise of 22.4%. The S&P 500 has gained 22.1% in the same time frame. Image Source: Zacks Investment Research More on the News Since the COVID-19 epidemic, the prevalence of depression among teenagers and young adults has increased. When compared to adult therapy alternatives, the existing options for teenagers' treatment are on the lower side. NeuroStar's TMS therapy presents a promising first-line treatment option for adolescents with remarkable response rates that are comparable to adult response rates and real-world evidence. This development may lead to a shift in the way that depression in young people is tr
Show less
Read more
Impact Snapshot
Event Time:
STIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STIM alerts
High impacting Neuronetics, Inc. news events
Weekly update
A roundup of the hottest topics
STIM
News
- GREENBROOK TMS REPORTS FISCAL YEAR 2023 OPERATIONAL AND FINANCIAL RESULTS [Yahoo! Finance]Yahoo! Finance
- Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call [Yahoo! Finance]Yahoo! Finance
- Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference CallGlobeNewswire
- New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital [Yahoo! Finance]Yahoo! Finance
- New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalGlobeNewswire
STIM
Earnings
- 3/5/24 - Beat
STIM
Sec Filings
- 4/11/24 - Form DEFA14A
- 4/11/24 - Form DEF
- 4/1/24 - Form SC
- STIM's page on the SEC website